ClinicalTrials.Veeva

Menu

Contribution of the Pharmacological Profile of the A2A Receptor to Adenosine in the Diagnosis of Myocardial Ischemia (RIMACI)

P

Public Assistance-Hospitals of Marseille (AP-HM)

Status

Unknown

Conditions

Chronic Coronary Artery Disease

Treatments

Biological: blood sample

Study type

Interventional

Funder types

Other

Identifiers

NCT04640844
2020-13
2020-A00686-33 (Other Identifier)

Details and patient eligibility

About

The chronic coronary artery disease could be detected by a drop in the expression of A2A receptors to adenosine, while high values of the KD / EC50 ratio are a sign of coronary ischemia. Knowing the number of A2A receptors in circulating lymphocytes could allow detection of coronary artery disease and evaluating the functionality of A2A receptors in circulating lymphocytes could allow quantification of myocardial ischemia.

Thus, a simple and unique blood sample would quickly detect patients with life-threatening coronary ischemia. This would avoid prolonged hospitalizations and costly non-invasive tests (stress echocardiography, myocardial scintigraphy) in patients without coronary artery disease.

Full description

The main objective of this study is to evaluate the discriminating capacities of A2A adenosine receptors expression on the surface of circulating lymphocytes for the detection of coronary artery disease in patients hospitalized for surgery of the aorta and / or arteries of the lower limbs.

The secondary objectives are:

Assessment of the discriminating capacities of the functionality (KD / EC50) of A2A adenosine receptors on the surface of circulating lymphocytes, for the diagnosis of myocardial ischemia in patients hospitalized for surgery of the aorta and / or arteries of legs.

Determinate the best threshold for discriminating patients with coronary artery disease and estimate the discriminating performance associated with this threshold.

Determinate the best threshold for discriminating patients with myocardial ischemia and estimate the discriminating performance associated with this threshold.

Enrollment

170 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients admitted for preoperative assessment of vascular surgery of the aorta and / or arteries of the lower limbs.
  • Adult person (age> 18).
  • Affiliated with a social security scheme.
  • Signature of informed consent.

Exclusion criteria

  • Patients with a history of coronary artery disease awaiting revascularization.
  • Hyperthyroidism, anemia (Hb <13 g / dL).
  • Contraindication to the practice of coronary angiography, stress echocardiography or myocardial scintigraphy.
  • Unstable hemodynamic state or cardiogenic shock.
  • Adults protected under guardianship, curatorship or legal protection.
  • Pregnant or lactating women

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

170 participants in 1 patient group

patients hospitalized
Experimental group
Description:
for surgery of the aorta and / or arteries of the lower limbs.
Treatment:
Biological: blood sample

Trial contacts and locations

1

Loading...

Central trial contact

ALAEXANDRA GIULIANI

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems